EuroQoL 5-Dimension 5-Level (EQ-5D-5L)

The EuroQol Group


Basic description

  • Developed in 2011
  • Another version exists for adolescents: EQ-5D-Y-5L

The EuroQol Group

© The Euroqol Group (English source and all translations and all adaptations)
EQ-5D™ is a trade mark of the EuroQol Group
To assess health outcome from a wide variety of interventions on a common scale, for purposes of evaluation, allocation and monitoring
Therapeutic area
  • Generic
Therapeutic indication


Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • Dutch for the Netherlands
  • Finnish for Finland
  • Norwegian for Norway
  • Swedish for Sweden
  • English for the UK
Bibliographic reference(s) of the original questionnaire

The EuroQol Group (1990). EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 16(3):199-208 (PubMed abstract)

Brooks R (1996). EuroQol: the current state of play. Health Policy 37(1):53-72 (PubMed abstract)

Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011 Dec;20(10):1727-36 (Full text article)

Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, Swinburn P, Busschbach J. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013 Sep;22(7):1717-27 (Full text article)

van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, Lloyd A, Scalone L, Kind P, Pickard AS. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value in Health. 2012 Jul-Aug;15(5):708-15 (Full text article)

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us